Baruch Halpert
Voorzitter bij Terragenic International Ltd.
Profiel
Baruch Halpert is currently the Executive Chairman at Terragenic International Ltd.
He previously worked as a Director at Enlivex Therapeutics Ltd.
and holds a graduate degree from The University of Reading.
Actieve functies van Baruch Halpert
| Bedrijven | Functie | Begin |
|---|---|---|
| Terragenic International Ltd. | Voorzitter | 01-01-2018 |
Eerdere bekende functies van Baruch Halpert
| Bedrijven | Functie | Einde |
|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Directeur/Bestuurslid | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Directeur/Bestuurslid | - |
Opleiding van Baruch Halpert
| The University of Reading | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
| Terragenic International Ltd. |
